Helping patients across multiple diseasesRevenue split by therapeutic areas1

Servicing a diversified customer baseRevenue split by customer type1

Solutions along the value chainRevenue split by business segment and number of active custom projects by stage of development1

1 Approximate splits as per 31 December 2021.

Business model Providing expert knowledge for peptide-based API's across the entire value chain

API – Active Pharmaceutical Ingredient; CMC – Chemistry, Manufacuring & Controls; GMP – Good Manufacturing Practice; ICH – International Council for Harmonization; LCM – Life Cycle Management; NDA – New Drug Application; PPQ – Process Performance Qualification.

Integrated strategyStriving to be the preferred long-term partner for customers


Footprint and customer proximityExperienced team1 and GMP-certified manufacturing network

1 Data based on headcount as of 31 December 2021.

Striving for profitable growthBuilding on favorable market trends

1 For a reconcilliation to the nearest IFRS line item, please refer to the section “Definitions and reconciliations” of this report.

This website uses cookies to ensure you get the best experience on our website.Privacy statement